MedEnvision has agreed a majority-stake private equity deal to support the international expansion of its surgical technology business. 🔗 Full story: buff.ly/AqIJbE6 #MedEnvision #Medtech #OrthopaedicSurgery #PrivateEquity #HealthcareInvestment

An ADHD drug will be tested alongside a diabetes medicine in a UK Alzheimer's trial designed to more than halve the time needed to assess treatments. 🔗 Full story: buff.ly/n8HTQWI #AlzheimersResearch #DementiaResearch #ClinicalTrials #DrugDevelopment #DementiaCare

Anaconda Biomed has raised €48.9m (US$56m) to complete a clinical study of its stroke clot-removal device and support development of new devices. 🔗 Full story: buff.ly/OJwXBhp #StrokeTreatment #Medtech #HealthcareInvestment #MedicalInnovation #StrokeRecovery

Diabetes may mask biological changes linked to Alzheimer's disease in the brain, potentially complicating research into the condition, a study suggests. 🔗 Full story: buff.ly/Mt2rq8y #AlzheimersResearch #Diabetes #DementiaResearch #BrainHealth #HealthyAgeing

Johns Hopkins University has secured US$20m over five years to develop AI and other technologies for Alzheimer's disease and ageing care. 🔗 Full story: buff.ly/klhDOo8 #AlzheimersResearch #ArtificialIntelligence #DementiaCare #AgeTech #HealthyAgeing

More greenspace within 100 metres of urban homes was linked to a 20 per cent lower dementia risk over 16 years, a study suggests. 🔗 Full story: buff.ly/22uwyg7 #DementiaResearch #BrainHealth #Greenspace #HealthyAgeing #UrbanPlanning

Acta Pharmaceuticals has secured US$24m in seed funding to develop experimental treatments aimed at early intervention in Alzheimer's disease. 🔗 Full story: buff.ly/J6Btky5 #Type2Diabetes #DiabetesTreatment #InsulinTherapy #DrugApproval #HealthcareInnovation

Ascensia and Sava have partnered to develop a less invasive glucose monitor that could become available in Europe within the next two years. 🔗 Full story: buff.ly/i3oz3yQ #Diabetes #GlucoseMonitoring #WearableTechnology #Medtech #HealthcareInnovation

The MHRA has authorised once-weekly insulin for adults with type 2 diabetes, potentially reducing injections from up to 365 a year to 52. 🔗 Full story: buff.ly/Yd4GUz6 #Type2Diabetes #DiabetesTreatment #InsulinTherapy #DrugApproval #HealthcareInnovation

TWENTY years after cells were reprogrammed in a petri-dish, the first human trial to reverse cellular ageing is showing promising initial results. 🔗 Full story: buff.ly/0OeVKbs #Longevity #AntiAgeing #ClinicalTrials #CellularReprogramming #HealthyAgeing

Exercise reduced Alzheimer's-like brain changes and improved memory in older mice after six weeks, a study suggests. 🔗 Full story: buff.ly/VcyModD #Alzheimers #DementiaResearch #Exercise #BrainHealth #HealthyAgeing

An AI tool can detect ageing in blood stem cells by analysing the three-dimensional organisation of DNA, researchers report. 🔗 Full story: buff.ly/oEyp6Ej #StemCells #ArtificialIntelligence #Longevity #AgeingResearch #HealthyAgeing

Jonathan's DNA has revealed genetic variants and chemical patterns that could offer clues to the longevity of the world's oldest living land animal. 🔗 Full story: buff.ly/kMQxQWp #Longevity #HealthyAgeing #Genetics #AgeingResearch #Science

A biotech developing a new type of Parkinson’s therapy has signed a licensing deal with Roche’s Genentech worth up to US$1.27bn. 🔗 Full story: buff.ly/m8TOO8g #Parkinsons #DrugDevelopment #Biotech #Neurodegeneration #AgeTech

People who are overweight or obese when diagnosed with dementia have a lower risk of death than those of normal weight, a study suggests. 🔗 Full story: buff.ly/mCoMM4D #Dementia #Obesity #HealthyAgeing #Nutrition #DementiaResearch

Scientists in the US are developing an AI system that interprets nonverbal communication and translates it into information caregivers can understand. 🔗 Full story: buff.ly/mgAF3AF #ArtificialIntelligence #AssistiveTechnology #Disability #Caregiving #HealthTech

The success of the fat-busting GLP-1 drug has supercharged the global peptide market which now has a valuation upwards of $100bn. 🔗 Full story: buff.ly/wWSq7pm #Peptides #GLP1 #Longevity #HealthyAgeing #Biohacking

British startup InTouchNow has raised £2.3m in seed funding to develop its AI voice agent for GP phone lines, which can detect patient frustration. 🔗 Full story: buff.ly/OeCMbAj #HealthTech #ArtificialIntelligence #PrimaryCare #NHS #DigitalHealth

London healthtech Lottie has acquired care billing specialist CareMaster, which provides software to 750+ UK care homes. 🔗 Full story: buff.ly/NNqMcWZ #CareTech #SocialCare #CareHomes #HealthTech #CareSoftware

Glucosamine use was linked to a higher dementia progression risk among people with mild cognitive impairment, a study suggests. 🔗 Full story: buff.ly/VIv443i #Alzheimers #Dementia #Glucosamine #BrainHealth #HealthyAgeing